CLIC News Roundup – June 15, 2021

SCTR-supported COVID-19 biorepository yields new insights into IgG antibody responses in patients with and without symptoms

People who successfully fight off COVID-19 without showing symptoms have much higher levels of IgG antibodies against the virus’s spike protein than do patients who were hospitalized with COVID-19, reports a research team led by Shikhar Mehrotra, Ph.D., of the Medical University of South Carolina (MUSC) in a recent issue of iScience.

Podcast episode discusses research into healthy aging of LGBTQ community members

Penn State Clinical and Translational Science Institute released the latest episode of its Engage Podcast discussing research into healthy aging in the LGBTQ community. Britney Wardecker, Ph.D., an assistant professor of nursing at Penn State College of Nursing, discusses her work into understanding the needs and health care preferences of aging LGBTQ community members.

Storytelling and Diversity: Using Your Story to Explore Diversity, Equity, and Inclusivity in Research

In this workshop, members of DC3 will share the journey of creating the event and the lessons learned which has led to further expansion of the resources they are able to provide. After sharing the lessons, they will use guided prompts to allow attendees to explore their own stories to see how your own story affects how they show up in the world and the research community.

June 16 at 2 pm ET

CTSA ReFRAME Call for Proposals

The Scripps Research Translational Institute and drug discovery affiliate Calibr invite proposals for collaborative drug repurposing screens. This translational endeavor aims to partner clinical proficiencies throughout the Clinical and Translational Science Awards (CTSA) network with drug discovery resources. CTSA-affiliated researchers and clinicians who have identified potential drug targets, pathways, or screening approaches and are interested in accelerated translation into patients through drug repurposing are encouraged to respond.

CLIC Un-Meeting: Exploring the Inclusion of Community Hospitals in Clinical Research

Researchers across the country gathered virtually last month to discuss outreach to community hospitals for recruitment and enrollment into clinical trials at the CLIC-hosted Un-Meeting “Exploring the Inclusion of Community Hospitals in Clinical Research.” The topic, chosen by the National Center for Advancing Translational Sciences (NCATS), was driven by the disconnect between high COVID patient numbers and a low number of people who enrolled in clinical trials during the pandemic. 

CLIC will be scheduling a “next steps” Un-Meeting for the fall of 2021 to continue the conversation. If you are interested in speaking, please contact the Un-Meetings team here: unmeetings@clic-ctsa.org. We are especially looking for speakers and attendees from community hospitals. Please pass this information along to anyone who might be interested.

From Brain Disorders to Brain Health: Prevention and Management of Cognitive Decline and Dementia

Check out this free, one-hour continuing medical education (CME) course from the University of Florida CTSI. Through this CME, cognitive health experts provide the latest information on the screening, diagnosis, and treatment of mild cognitive impairment and dementia, including referral to specialty care.

Join the CLIC Career Development Community!

Novavax Covid-19 vaccine highly effective in a late-stage trial, long-awaited results show

Novavax’s Covid-19 vaccine was highly effective in preventing symptomatic infections, hospitalizations, and severe illnesses, long-awaited results from the company’s Phase 3 trial, released Monday, revealed. The vaccine was 90% protective against laboratory-confirmed symptomatic infection.

Outcomes of COVID-19 in Patients With Cancer: Report From the National COVID Cohort Collaborative (N3C)

The N3C article authored by Noha Sharafeldin, MD, PhD, MSc, et al has been published in the Journal of Clinical Oncology. The authors assembled the largest nationally representative cohort of patients with cancer and COVID-19 to date and identified demographic and clinical factors associated with increased all-cause mortality in patients with cancer.

View all posts